Acidrine in the management of gastritis and duodenitis. A double-blind placebo controlled clinical trial.
Thirty-nine adult out-patients with dyspepsia and endoscopically proven gastritis and/or duodenitis without ulcer, completed a double-blind, placebo controlled, 8-week clinical trial of either Acidrine (twenty-one patients) or placebo (eighteen patients), at a daily dosage of 2 tablets t.i.d. Treatment with Acidrine resulted in a significant improvement in symptoms and in the endoscopic appearance of the gastritis and duodenitis when compared with placebo.
D000328:Adult; D000535:Aluminum / Q000627:therapeutic use*; D001952:Bridged-Ring Compounds / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D004382:Duodenitis / Q000188:drug therapy*; D005260:Female; D005756:Gastritis / Q000188:drug therapy*; D005773:Gastroscopy; D006801:Humans; D008297:Male; D009942:Organometallic Compounds; D011134:Polysaccharides / Q000627:therapeutic use*; D011897:Random Allocation
D001952:Bridged-Ring Compounds; D004338:Drug Combinations; D009942:Organometallic Compounds; D011134:Polysaccharides; C011625:aluminium glycinate, myrtecaine drug combination; D000535:Aluminum